Porth Ymchwil

Cost-effectiveness considerations in pharmacogenetics.

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

StandardStandard

Cost-effectiveness considerations in pharmacogenetics. / Hughes, D.; Hughes, D.A.
2008. Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain..

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

HarvardHarvard

Hughes, D & Hughes, DA 2008, 'Cost-effectiveness considerations in pharmacogenetics.', Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain., 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2008). Cost-effectiveness considerations in pharmacogenetics.. Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain..

CBE

Hughes D, Hughes DA. 2008. Cost-effectiveness considerations in pharmacogenetics. Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain..

MLA

Hughes, D. a D.A. Hughes Cost-effectiveness considerations in pharmacogenetics.. European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain., 03 Ion 0001, Papur, 2008.

VancouverVancouver

Hughes D, Hughes DA. Cost-effectiveness considerations in pharmacogenetics.. 2008. Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain..

Author

Hughes, D. ; Hughes, D.A. / Cost-effectiveness considerations in pharmacogenetics. Papur a gyflwynwyd yn European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain..

RIS

TY - CONF

T1 - Cost-effectiveness considerations in pharmacogenetics.

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2008/1/1

Y1 - 2008/1/1

M3 - Paper

T2 - European Science Foundations - Universitat de Barcelona, Conference in Biomedicine, Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions, Barcelona, Spain.

Y2 - 3 January 0001

ER -